The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQXT.L Regulatory News (QXT)

  • There is currently no data for QXT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update and Notice of Results

16 Jan 2023 07:00

RNS Number : 7481M
Quixant PLC
16 January 2023
 

16 January 2023

Quixant plc

("Quixant" or the "Group")

Trading Update and Notice of Results

Record annual revenues

 

Quixant (AIM:QXT), a leading provider of innovative, highly engineered technology products principally for the global gaming and broadcast industries, provides an update on trading for the financial year ended 31 December 2022 ("FY22").

 

Trading

 

The Board is pleased to confirm that, further to upgrading FY22 revenue expectations on 13 October 2022, positive trading across both the Gaming and Densitron businesses continued through the fourth quarter, reflecting the strong demand for our products. The Board expects to report full year revenues of $119.9m, 38% up year-on-year, the highest revenue performance in the Group's history, and slightly ahead of market expectations1. This is despite the backdrop of substantial supply and economic disruption. The Gaming business posted revenues of $74.1m, representing its best performance since 2018 and the Densitron business delivered $45.8m, beating the revenue record set in FY21 by 15%. 

 

The Group expects adjusted profit before tax to be slightly ahead of market expectations1. Whilst supply chain challenges persisted through the second half of FY22, a stabilisation in component pricing led to a partial recovery in gross margins towards historic levels.

 

FY22

FY21

Change

($m)

($m)

 

Group Revenue

119.9

87.1

38%

Gaming Revenue

74.1

 

47.3

 

57%

Densitron Revenue

45.8

 

39.8

 

15%

 

 

 

 

 

 

Financial position

 

Net cash at 31 December 2022 increased to $12.9m from $12.0m at 30 June 2022, driven by lower working capital requirements as the Group reduced the level of its strategic inventory holdings.

 

Outlook

 

The Group starts the new financial year with a strong order book, which provides good forward visibility supporting further revenue growth in FY23. Management continues to monitor macro-economic challenges, including recession, ongoing supply risks and inflationary pressures, but believes that the Group is well placed to continue to deliver good growth given its resilient end-markets and strategic positioning.

 

Notice of Results

The Group expects to report its full year results for 2022 on 21 March 2023.

Jon Jayal, Chief Executive Officer of Quixant plc, commented: "The Group has delivered an excellent year of growth, significantly ahead of initial expectations. Against a backdrop characterised by substantial supply and economic disruption, this performance is even more pleasing.

 

"This is testament to the strength of our customer relationships, quality of our people, resiliency in our management of supply chains and the value attributed to our innovative technology solutions. Driven by our growth strategy, we have exited the year with a more diversified product set, broader customer base and more robust platform from which to grow.

 

"As we start the new year, we remain cognisant of wider recessionary challenges however a robust order book supports further growth in FY23. We believe our business strategy positions us well for long-term diversified growth in the Group's revenue and profits."

 

1 The current range of forecasts for the year ended 31 December 2022 is revenue of between $115.3m and $115.1m with a consensus of $115.2m and adjusted profit before tax of $10.1m.

 

 

Quixant plc

Jon Jayal, Chief Executive Officer

Johan Olivier, Chief Financial Officer

 

Tel: +44 (0)1223 892 696

Nominated Adviser and Broker:

finnCap Ltd

Matt Goode / Simon Hicks (Corporate Finance)

Alice Lane / Charlotte Sutcliffe (ECM)

 

Tel: +44 (0) 20 7220 0500

Joint Broker:

Canaccord Genuity Limited

Simon Bridges / Andrew Potts

 

Tel: +44 (0) 20 7523 8000

Financial PR:

Alma PR

Hilary Buchanan / Kieran Breheny / Will Ellis Hancock

Tel: +44 (0)20 3405 0205

 

About Quixant

Quixant, founded in 2005, designs and manufactures highly optimised computing solutions and monitors principally for the global gaming and broadcast industries. The Company is headquartered in Cambridge in the UK, with offices throughout Europe, North America and Asia. Quixant has its own manufacturing and engineering operation based in Taiwan and software engineering and customer support teams based in Italy and Slovenia. All the specialised products software and manufacturing are produced in-house and Quixant owns all its own IP some of which is protected by patents and design rights.

In November 2015 Quixant acquired Densitron Technologies plc. Densitron has a strong heritage in the sale of electronic display solutions to global industrial markets. Through Densitron's experienced sales team, Quixant has a robust platform to build its business into wider industrial markets. In-depth information on the Company's products, markets, activities and history can be found on the corporate website at www.quixant.com.

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTGZGMMZKNGFZM
Date   Source Headline
11th Jun 20193:00 pmRNSHolding(s) in Company
21st May 20194:39 pmRNSHolding(s) in Company
3rd May 201911:07 amRNSDirector/PDMR Shareholding
1st May 20194:09 pmRNSGrant of Options
1st May 20194:03 pmRNSExercise of Options
18th Apr 20194:49 pmRNSExercise of Options
16th Apr 201911:13 amRNSResult of AGM
10th Apr 20197:00 amRNSDirector/PDMR Shareholding
4th Apr 20195:57 pmRNSGrant of Options
4th Apr 20191:54 pmRNSGrant of Options
27th Mar 20197:00 amRNSDirector/PDMR Shareholding
25th Mar 20197:00 amRNSFinal Results
24th Jan 20197:00 amRNSTrading Update and Notice of Results
21st Jan 20192:51 pmRNSHolding(s) in Company
4th Jan 201910:13 amRNSBoard Change
22nd Oct 20189:41 amRNSIssue of Equity & PDMR Dealing
5th Oct 20185:50 pmRNSIssue of Options & Director/PDMR Dealings
21st Sep 20187:40 amRNSHolding(s) in Company
19th Sep 20187:00 amRNSHalf-year Report
19th Jul 20187:00 amRNSTrading Update and Notice of Results
4th Jul 20184:36 pmRNSDirector/PDMR Shareholding
14th May 20188:07 amRNSHolding(s) in Company
11th May 20184:10 pmRNSDirector/PDMR Dealings
30th Apr 20187:00 amRNSDirector/PDMR Shareholdings
27th Apr 20182:15 pmRNSResult of placing in Quixant plc
27th Apr 20189:50 amRNSProposed placing in Quixant plc
24th Apr 201811:14 amRNSResult of AGM
5th Apr 20183:23 pmRNSGrant of Options
26th Mar 20184:18 pmRNSDividend Timetable
22nd Mar 20187:00 amRNSFinal Results
1st Mar 20187:00 amRNSBoard Changes and Appointment of CFO
2nd Feb 201810:08 amRNSHolding(s) in Company
25th Jan 20187:00 amRNSTrading Update and Notice of Results
28th Nov 20171:59 pmRNSDirector/PDMR Shareholding
27th Oct 20175:15 pmRNSIssue of Equity and Director/PDMR Shareholding
4th Oct 20172:23 pmRNSHolding(s) in Company
21st Sep 20177:03 amRNSHolding(s) in Company
21st Sep 20177:00 amRNSHalf-year Report
11th Sep 20173:00 pmRNSHolding(s) in Company
22nd Aug 201710:16 amRNSHolding(s) in Company
7th Aug 20177:00 amRNSNotice of Results
24th Jul 20177:00 amRNSTrading Update and Notice of Results
13th Jul 201710:25 amRNSHolding(s) in Company
2nd Jun 20178:00 amRNSDirector/PDMR Shareholding
12th May 20174:55 pmRNSDirector/PDMR Shareholding
4th May 20172:37 pmRNSIssue of Equity and Director/PDMR Dealings
25th Apr 201712:15 pmRNSResult of AGM
22nd Mar 201712:00 pmRNSBoard Appointment
22nd Mar 201710:00 amRNSDividend Timetable
22nd Mar 20177:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.